- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
LDL Can Help Promote Cancer Metastasis
Researchers have identified that other than clogging the arteries, LDL can also promote metastatic cancer cells, which break away from the parent tumor, to reattach at distant site.
In a world-first, University of Sydney researchers have discovered one of the main reasons behind why cancer spreads throughout the body - the help of 'bad' cholesterol.
Published in top international journal,
Cell Reports
, the research found 'bad'
(Low Density Lipoprotein, or LDL) regulates the machinery that controls cell migration, a major finding in the search to explain why cancer spreads throughout the body.
Paper senior author, Associate Professor Thomas Grewal from the University's Faculty of Pharmacy, said the research had important implications for cancer research.
"One of the things that makes cancer so difficult to treat is the fact that it can spread around the body," he said.
"Most of the cells in our bodies stick to neighbouring cells through the help of 'Velcro-like' molecules on their surface known as integrins. Unfortunately, integrins also help cancer cells that have broken away from a cancerous tumour to take root elsewhere in the body.
"Our study identified that 'bad' (LDL) cholesterol controls the trafficking of tiny vessels which also contain these integrins, and this has huge effects on the ability of cancer cells to move and spread throughout the body.
Read the article here: http://bit.ly/1kPEKpj
Source: MedicalXpress
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
